Mercury Fund is a Houston-based venture capital firm founded in 2005, with an additional office in Ann Arbor. The firm specializes in early-stage investments, primarily focusing on technology-related companies in the U.S. Midcontinent. With over $200 million in assets under management, Mercury seeks out innovative startup opportunities, particularly those led by entrepreneurs who have demonstrated product-market fit and are prepared for growth. Known for its active involvement in the region, Mercury has positioned itself as a key partner for both new entrepreneurs requiring guidance and experienced founders looking to capitalize on the resources and talent available in Middle America.
Label Insight collects, aggregates and analyzes CPG label data to allow the government, retailers, manufacturers and app developers a comprehensive view of food labels. This includes allergens, additives, ingredient, and claims analysis.
Label Insight collects, aggregates and analyzes CPG label data to allow the government, retailers, manufacturers and app developers a comprehensive view of food labels. This includes allergens, additives, ingredient, and claims analysis.
Label Insight collects, aggregates and analyzes CPG label data to allow the government, retailers, manufacturers and app developers a comprehensive view of food labels. This includes allergens, additives, ingredient, and claims analysis.
Label Insight collects, aggregates and analyzes CPG label data to allow the government, retailers, manufacturers and app developers a comprehensive view of food labels. This includes allergens, additives, ingredient, and claims analysis.
Prolacta Bioscience Inc. develops and produces standardized human milk-based nutritional products for premature and critically ill infants in the neonatal intensive care unit (NICU). It offers human milk-based human milk fortifiers; human milk caloric fortifiers; standardized human milk; a ready-to-feed human milk-based premature infant formula; and solutions for early/trophic feeds and full feeds. The company was incorporated in 1999 and is headquartered in Duarte, California.
Prolacta Bioscience Inc. develops and produces standardized human milk-based nutritional products for premature and critically ill infants in the neonatal intensive care unit (NICU). It offers human milk-based human milk fortifiers; human milk caloric fortifiers; standardized human milk; a ready-to-feed human milk-based premature infant formula; and solutions for early/trophic feeds and full feeds. The company was incorporated in 1999 and is headquartered in Duarte, California.